Cargando…
Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
BACKGROUND: In recent years, a plethora of therapeutic agents for ulcerative colitis (UC), especially novel biologics (Bio), have become available. Although it is now possible to use biological drugs, there should be no need for frequently changing medications. To avoid first-pass metabolism in the...
Autores principales: | Shibuya, Tomoyoshi, Nomura, Kei, Okahara, Koki, Haga, Keiichi, Nomura, Osamu, Murakami, Takashi, Uchida, Shino, Kodani, Tomohiro, Ishikawa, Dai, Sakamoto, Naoto, Ogihara, Tatsuo, Osada, Taro, Nagahara, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939661/ https://www.ncbi.nlm.nih.gov/pubmed/31865359 http://dx.doi.org/10.12659/MSM.918562 |
Ejemplares similares
-
Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2020) -
Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus
por: Shibuya, Tomoyoshi, et al.
Publicado: (2018) -
Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation
por: Okahara, Koki, et al.
Publicado: (2020) -
Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis
por: Nomura, Kei, et al.
Publicado: (2021) -
Efficacy and Acceptability of 1 Liter of Polyethylene Glycol with Ascorbic Acid vs. 2 Liters of Polyethylene Glycol Plus Mosapride and Sennoside for Colonoscopy Preparation
por: Kamei, Masato, et al.
Publicado: (2018)